Garrett M Draper

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 6

Top Topics

Inflammatory Response

Top Venues

bioRxiv : the preprint server for biology

Molecular cancer therapeutics

Genes, chromosomes & cancer

This page only lists publications with an associated author ORCID identifier.

Publications

Kyle B Williams, Alex T Larsson, Bryant J Keller, Katherine E Chaney, Rory L Williams, Minu M Bhunia, Garrett M Draper, Tyler A Jubenville, Sue K Rathe, Christopher L Moertel, Nancy Ratner, David A Largaespada
Pharmacogenomic synthetic lethal screens reveal hidden vulnerabilities and new therapeutic approaches for treatment of NF1-associated tumors. bioRxiv : the preprint server for biology (2024)
Kyle B Williams, Alex T Larsson, Bryant J Keller, Katherine E Chaney, Rory L Williams, Minu M Bhunia, Garrett M Draper, Tyler A Jubenville, Sue K Rathe, Christopher L Moertel, Nancy Ratner, David A Largaespada
Pharmacogenomic synthetic lethal screens reveal hidden vulnerabilities and new therapeutic approaches for treatment of NF1-associated tumors. bioRxiv : the preprint server for biology (2024)
Kyle B Williams, Alex T Larsson, Bryant J Keller, Katherine E Chaney, Rory L Williams, Minu M Bhunia, Garrett M Draper, Tyler A Jubenville, Sue K Rathe, Christopher L Moertel, Nancy Ratner, David A Largaespada
Pharmacogenomic synthetic lethal screens reveal hidden vulnerabilities and new therapeutic approaches for treatment of NF1-associated tumors. bioRxiv : the preprint server for biology (2024)
Kyle B Williams, Alex T Larsson, Bryant J Keller, Katherine E Chaney, Rory L Williams, Minu M Bhunia, Garrett M Draper, Tyler A Jubenville, Sue K Rathe, Christopher L Moertel, Nancy Ratner, David A Largaespada
Pharmacogenomic synthetic lethal screens reveal hidden vulnerabilities and new therapeutic approaches for treatment of NF1-associated tumors. bioRxiv : the preprint server for biology (2024)
Garrett M Draper, Daniel J Panken, David A Largaespada
Modeling human cancer predisposition syndromes using CRISPR/Cas9 in human cell line models. Genes, chromosomes & cancer (2023)
Branden A Smeester, Garrett M Draper, Nicholas J Slipek, Alex T Larsson, Natalie Stratton, Emily J Pomeroy, Kelsie L Becklin, Kenta Yamamoto, Kyle B Williams, Kanut Laoharawee, Joseph J Peterson, Juan E Abrahante, Susan K Rathe, Lauren J Mills, Margaret R Crosby, Wendy A Hudson, Eric P Rahrmann, David A Largaespada, Branden S Moriarity
Implication of ZNF217 in Accelerating Tumor Development and Therapeutically Targeting ZNF217-Induced PI3K-AKT Signaling for the Treatment of Metastatic Osteosarcoma. Molecular cancer therapeutics 19 (12) (2020)